|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.870 USD | -2.24% |
|
-6.53% | -32.33% |
| 07-07 | RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating | MT |
| 07-03 | CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CRMD Stock
- Consensus CorMedix Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
